Praxis Precision Medicines, Inc. (34)

Browse by Contract Category

Contracts

Transition Agreement dated July 26, 2022, by and between Praxis Precision Medicines, Inc. and Bernard Ravina (Filed With SEC on July 26, 2022)
Description of Securities of Praxis Precision Medicines, Inc (Filed With SEC on February 28, 2022)
Sublease dated May 27, 2021 (Filed With SEC on June 2, 2021)
Form of Underwriting Agreement (Filed With SEC on May 11, 2021)
Form of Director Indemnification Agreement, as amended (Filed With SEC on October 9, 2020)
License Agreement, dated December 31, 2017, by and between Purdue Neuroscience Company and the Registrant (Filed With SEC on September 25, 2020)
Non-Employee Director Compensation Policy (Filed With SEC on February 28, 2022)
Amended and Restated Employment Agreement, dated October 20, 2020, by and between Praxis Precision Medicines, Inc. and Nicole Sweeny (Filed With SEC on February 28, 2022)
Amended and Restated Employment Agreement, dated October 20, 2020, by and between Praxis Precision Medicines, Inc. and Bernard Ravina (Filed With SEC on February 28, 2022)
Amended and Restated Employment Agreement (Filed With SEC on February 28, 2022)
Retention Ince (Filed With SEC on August 30, 2021)
Praxis Precision Medicines, Inc. 2017 Stock Incentive Plan, as amended, and form of award agreements thereunder (Filed With SEC on March 17, 2021)
Description of Securities of Praxis Precision Medicines, Inc (Filed With SEC on March 17, 2021)
Form of Amended and Restated Employment Agreement (Filed With SEC on November 23, 2020)
Form of Restricted Stock Award Agreement for Company Employees under the Registrants 2020 Stock Option and Incentive Plan (Filed With SEC on October 9, 2020)
Non-Employee Director Compensation Policy (Filed With SEC on October 9, 2020)
2020 Employee Stock Purchase Plan (Filed With SEC on October 9, 2020)
Form of Restricted Stock Award Agreement for Non-Employee Directors under the Registrants 2020 Stock Option and Incentive Plan (Filed With SEC on October 9, 2020)
Form of Restricted Stock Award Agreement under the Registrants 2020 Stock Option and Incentive Plan (Filed With SEC on October 9, 2020)
Form of Non-Qualified Stock Option Agreement for Company Employees under the Registrants 2020 Stock Option and Incentive Plan (Filed With SEC on October 9, 2020)
Form of Incentive Stock Option Agreement under the Registrants 2020 Stock Option and Incentive Plan (Filed With SEC on October 9, 2020)
Form of 2020 Stock Option and Incentive Plan (Filed With SEC on October 9, 2020)
Specimen Common Stock Certificate (Filed With SEC on October 9, 2020)
Form of Underwriting Agreement (Filed With SEC on October 9, 2020)
Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under the Registrants 2020 Stock Option and Incentive Plan (Filed With SEC on October 9, 2020)
Form of Director Indemnification Agreement (Filed With SEC on September 25, 2020)
Form of Amended and Restated Employment Agreement (Filed With SEC on September 25, 2020)
Form of Officer Indemnification Agreement (Filed With SEC on September 25, 2020)
Praxis Precision Medicines, Inc. 2017 Stock Incentive Plan, as amended, and form of award agreements thereunder (Filed With SEC on September 25, 2020)
Consent to Sublease, First Amendment of Lease and Amendment, dated November 2, 2018, by and among Highland Capital Partners, LLC, MIT One Broadway, LLC and the Registrant (Filed With SEC on September 25, 2020)
Cooperation and License Agreement, dated September 11, 2019, by and between RogCon Inc. and the Registrant (Filed With SEC on September 25, 2020)
Research Collaboration, Option and License Agreement, dated September 11, 2019, by and between Ionis Pharmaceuticals, Inc. and the Registrant (Filed With SEC on September 25, 2020)
Sublease, dated October 4, 2018, by and between Highland Capital Partners, LLC and the Registrant (Filed With SEC on September 25, 2020)
Fourth Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, effective as of July 24, 2020 (Filed With SEC on September 25, 2020)